Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, Páleníček T, Redjep O, Repantis D, Schoevers RA, Septimus B, Simmons HJ, Soares JC, Somers M, Stansfield SC, Stuart JR, Tadley HH, Thiara NK, Tsai J, Wahba M, Williams S, Winzer RI, Young AH, Young MB, Zisook S, Malievskaia E.

Open source

DOI
10.1016/j.jad.2023.01.108
Published
2023-02-04
Container
J Affect Disord
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jad.2023.01.108,
  title = {Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.},
  author = {Goodwin GM and  Aaronson ST and  Alvarez O and  Atli M and  Bennett JC and  Croal M and  DeBattista C and  Dunlop BW and  Feifel D and  Hellerstein DJ and  Husain MI and  Kelly JR and  Lennard-Jones MR and  Licht RW and  Marwood L and  Mistry S and  Páleníček T and  Redjep O and  Repantis D and  Schoevers RA and  Septimus B and  Simmons HJ and  Soares JC and  Somers M and  Stansfield SC and  Stuart JR and  Tadley HH and  Thiara NK and  Tsai J and  Wahba M and  Williams S and  Winzer RI and  Young AH and  Young MB and  Zisook S and  Malievskaia E.},
  year = {2023},
  journal = {J Affect Disord},
  doi = {10.1016/j.jad.2023.01.108},
  url = {https://doi.org/10.1016/j.jad.2023.01.108}
}

RIS

TY  - JOUR
TI  - Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
AU  - Goodwin GM
AU  -  Aaronson ST
AU  -  Alvarez O
AU  -  Atli M
AU  -  Bennett JC
AU  -  Croal M
AU  -  DeBattista C
AU  -  Dunlop BW
AU  -  Feifel D
AU  -  Hellerstein DJ
AU  -  Husain MI
AU  -  Kelly JR
AU  -  Lennard-Jones MR
AU  -  Licht RW
AU  -  Marwood L
AU  -  Mistry S
AU  -  Páleníček T
AU  -  Redjep O
AU  -  Repantis D
AU  -  Schoevers RA
AU  -  Septimus B
AU  -  Simmons HJ
AU  -  Soares JC
AU  -  Somers M
AU  -  Stansfield SC
AU  -  Stuart JR
AU  -  Tadley HH
AU  -  Thiara NK
AU  -  Tsai J
AU  -  Wahba M
AU  -  Williams S
AU  -  Winzer RI
AU  -  Young AH
AU  -  Young MB
AU  -  Zisook S
AU  -  Malievskaia E.
PY  - 2023
JO  - J Affect Disord
DO  - 10.1016/j.jad.2023.01.108
UR  - https://doi.org/10.1016/j.jad.2023.01.108
ER  - 

APA

GM, G., ST, A., O, A., M, A., JC, B., M, C., C, D., BW, D., D, F., DJ, H., MI, H., JR, K., MR, L., RW, L., L, M., S, M., T, P., O, R., D, R., RA, S., B, S., HJ, S., JC, S., M, S., SC, S., JR, S., HH, T., NK, T., J, T., M, W., S, W., RI, W., AH, Y., MB, Y., S, Z., & E., M. (2023). Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.. J Affect Disord. https://doi.org/10.1016/j.jad.2023.01.108

Source records